可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Visse R,Nagase H. Matrix metallo proteinases and tissue inhibitors of metallo proteinases structure, function, and biochemistry [J]. Circ Res, 2003, 92(8): 827839.
[2] 顾俊,王长谦.基质金属蛋白酶与冠脉再狭窄[J].心脏杂志,2005,17(1):77-80.
[3]周启林,田国平.CD40CD40L与急性冠脉综合征的研究进展[J].心脏杂志,2006,18(2):239-241.
[4] 殷忠,李兰荪,张荣庆,等.急性冠脉综合征患者外周血MMP9及CRP的变化及临床意义[J].心脏杂志,2006,18(3):318-319,322.
[5] 张军,贾国良,王海昌,等.大鼠心肌梗死后心肌NFκB、MMP2和TIMP2表达变化及其意义[J].心脏杂志,2006,18(1):54-56,59.
[6] Uesugi N, Sakata N. Role of integrins, including α8, for neointima formation after vascular injury[J]. Cardiovasc Res, 2005,65(4): 766-767.
[7] Abid MR, Yano K, Guo S,et al. Forkhead transcription factors inhibit Vascular smooth muscle cell proliferation and neointimal hyperplasia[J].J Biol Chem, 2005, 280(33): 29864-29873.
[8] Smeglin A,Frishman WH. E lastinolytic matrix metalloproteinases and their inhibitors as the rapeutic targets in the a the rosclerotic plaque instability[J]. Cardiol Rev, 2004, 12(3):141-150.
[9] Newby AC. Dual role of matrix metalloproteinases (matrix) in intimal thickening and a the rosclerotic plaque rupture [J]. Physiol Rev, 2005, 85(1): 1-31.
[10]Defawe OD, Kenagy RD, Choi C, et al.MMP9 regulates both positively and negtively collagen gel contraction a nonproteolytic function of MMP9[J], Cardiovasc Res, 2005,66(2): 402-409.